Agenda*

Unlock the Future of Mental Healthcare at NEI Spring Congress!

Join us at the NEI Spring Congress for an unparalleled opportunity to enhance your clinical expertise. From foundational treatments to the latest breakthroughs. At NEI Spring Congress, you'll gain exclusive access to the most current research and actionable insights, empowering you to confidently tackle even the most complex cases. Don't miss this opportunity to stay ahead in the ever-evolving field of mental healthcare.

Register Today and Stay at the Cutting Edge!

May 8-10, 2025 | Philadelphia

Wednesday, May 7

3:00 pm – 8:00 pm

Check-In and Help Desk

7:30 pm – 8:30 pm

CME Dinner Session: A Gut Feeling: Dr. Roger McIntyre's 20-Year Journey of Research on GLP-1

— Roger S. McIntyre, MD, FRCPC and Andrew J. Cutler, MD

Limited seating. RSVP required. For in-person attendees only.

Thursday, May 8

6:15 am – 6:30 pm

Check-In and Help Desk

6:50 am – 7:00 am

Breakfast Check-In

— Level 5, Salons G-L

7:00 am – 8:00 am

Breakfast Industry Session†: An Established Treatment Option for Managing Bipolar I Disorder or Schizophrenia

Sponsored by Alkermes

— Gustavo Alva, MD, DFAPA

— Level 5, Salons G-L

8:10 am – 8:15 am

Chair’s Opening Remarks

— Roger S. McIntyre, MD, FRCPC

8:15 am – 9:25 am

Musc-y With a Chance of Glu: Advances in Our Understanding of Cortical Networks Involved in Cognitive Impairment Associated With Schizophrenia

— Andrew J. Cutler, MD and Roger S. McIntyre, MD, FRCPC

9:25 am – 10:25 am

Not Your Grandpa’s Antipsychotic: Optimizing Treatment for Schizophrenia Utilizing Novel Muscarinic Treatment Strategies

— Leslie Citrome, MD, MPH

10:25 am – 11:10 am

Exhibit Hall Opening

— Franklin B

11:10 am – 11:55 am

A Chaotic Mind: What's All The Commotion with Dissociation?

— Thomas L. Schwartz, MD

11:55 am – 12:05 pm

Meet Me at the Water Cooler: LAIs in Mood Disorders

— Leslie Citrome, MD, MPH and Desiree M. Matthews, MSN, PMHNP-BC

12:15 pm – 1:15 pm

Lunch Industry Session†: Learn About a Different Treatment Option for Adults with Schizophrenia: Where Does It Fit in Your Practice

Sponsored by Bristol Myers Squibb

— Michael Asbach DMsc, PA-C

— Level 5, Salons G-L

1:20 pm – 1:25 pm

Afternoon Kick-Off Remarks

— Level 5, Salons A-F

1:25 pm – 2:35 pm

A More Tailored and Swift Approach? Using Clinical Endophenotypes to Address Major Depressive Disorder in All of Its Variations

— Roger S. McIntyre, MD, FRCPC

2:35 pm – 3:30 pm

In Everyone’s Best Interest: Protecting Patients and Prescribers From the Consequences of Neglected Tardive Dyskinesia

— Desiree M. Matthews, MSN, PMHNP-BC

3:30 pm – 4:15 pm

Exhibit Hall Break

— Franklin B

4:15 pm – 5:10 pm

Ending the Tyranny of Trauma: Emerging Strategies in the Management of PTSD

— Hara E. Oyedeji, PMHNP-BC, MS, MSed and Roger S. McIntyre, MD, FRCPC

5:10 pm – 5:20 pm

Meet Me at the Water Cooler: Cognitive Impairment Associated With Schizophrenia

— Jonathan M. Meyer, MD and Andrew J. Cutler, MD

5:20 pm – 6:20 pm

All the Tea on ADHD: Guidance for Developing Effective Treatment Strategies for Patients With ADHD

— Andrew J. Cutler, MD

6:30 pm – 7:30 pm

Dinner Industry Session†: Treating MDD: A Rapid-Acting Oral Antidepressant with Multimodal Activity

Sponsored by Axsome Therapeutics

— Jonathan M. Meyer, MD and Erin Crown, MHSPAS, PA-C, CAQ-Psychiatry

— Level 5, Salons G-L

Friday, May 9

7:00 am – 6:30 pm

Check-In and Help Desk

6:50 am – 7:00 am

Breakfast Check-In

— Level 5, Salons G-L

7:00 am – 8:00 am

Breakfast Industry Session†: Bipolar II Depression: Clinical Differentiation From MDD and an FDA-Approved Treatment

Sponsored by Intra-Cellular Therapies, Inc.

— David J. Scheiderer, MD, MBA, DFAPA

— Level 5, Salons G-L

8:10 am – 8:15 am

Morning Kick-Off Remarks

— Level 5, Salons A-F

8:15 am – 9:15 am

Putting an SDA-PA to “Antipsychotic” Nomenclature: Improving Patient Engagement and Outcomes in the Pharmacological Treatment of Psychiatric Issues

— Joseph F. Goldberg, MD and Andrew J. Cutler, MD

9:15 am – 10:45 am

Exhibit Hall Break & Scientific Poster Session†

— Franklin B

10:45 am – 11:45 am

From Unipolar to Bipolar (and Everything In Between): Identifying and Treating Depression Across the Entire Mood Disorders Spectrum

— Joseph F. Goldberg, MD and Andrew J. Cutler, MD

11:45 am – 11:55 am

Meet Me at the Water Cooler: Tardive Dyskinesia in Mood Disorders

— Desiree M. Matthews, MSN, PMHNP-BC and Roger S. McIntyre, MD, FRCPC

12:05 pm – 1:05 pm

Lunch Industry Session†: Schizophrenia A to Z: From Pathophysiology to Functional Impact and Management

Sponsored by Boehringer Ingelheim

— Amber Hoberg, MSN, APRN, PMHNP-BC, Dost Öngür, MD, PhD, and Derek Phillips, PsyD, MSCP

— Level 5, Salons G-L

1:05 pm – 1:15 pm

Afternoon Kick-Off Remarks

— Level 5, Salons A-F

1:15 pm – 2:15 pm

You and I and an LAI: Benefits, Early Adoption, and Options for Patients With Serious Mental Illness

— Desiree M. Matthews, MSN, PMHNP-BC and Jonathan M. Meyer, MD

2:15 pm – 2:25 pm

Meet Me at the Water Cooler: Sleep

— Jade Wu, PhD, DBSM and Thomas L. Schwartz, MD

2:25 pm – 3:10 pm

Stopping the Spiral: Medication and Practical CBT Strategies for Anxiety Disorders

— Jeffrey R. Strawn, MD and Katherine K. Dahlsgaard, PhD, ABPP

3:10 pm – 3:25 pm

Networking Break

3:25 pm – 4:20 pm

A Moment on the Lips, Forever on the …Brain? The Effects of Metabolic Dysregulation on Cognition and Mood

— Roger S. McIntyre, MD, FRCPC

4:20 pm – 5:05 pm

Is There an App for That? Utilizing Digital Applications in the Management of Mental Health Issues

— Jade Wu, PhD, DBSM and Andrew J. Cutler, MD

5:05 pm – 5:50 pm

Faculty Feud! Sleep

— Andrew J. Cutler, MD (host), Jade Wu, PhD, DBSM, Thomas L. Schwartz, MD, Jeffrey R. Strawn, MD and Katherine K. Dahlsgaard, PhD, ABPP

6:00 pm – 7:00 pm

Dinner Industry Session†: Exploring the Role of an Adjunctive Therapy for Patients with Major Depressive Disorder

Sponsored by Otsuka America Pharmaceutical, Inc.

— Gustavo Alva, MD, DFAPA

— Level 5, Salons G-L

Saturday, May 10

7:00 am – 1:30 pm

Check-In and Help Desk

6:50 am – 7:00 am

Breakfast Check-In

— Level 5, Salons G-L

7:00 am – 8:00 am

Breakfast Industry Session†: Realizing the Potential of Digital Therapeutics: An Evaluation of Clinical Evidence and Prospective Benefits

Sponsored by Boehringer Ingelheim

— Daniel Fulford, PhD and Lisa Marsch, PhD

— Level 5, Salons G-L

8:10 am – 8:15 am

Chair’s Final Remarks

— Roger S. McIntyre, MD, FRCPC

8:15 am – 9:10 am

A Practical Guide to Ordering and Interpreting Kidney Function Tests

— Rajnish Mago, MD

9:10 am – 9:20 am

Meet Me at the Water Cooler: Metabolic Side Effects

— Rajnish Mago, MD and Roger S. McIntyre, MD, FRCPC

9:20 am – 10:05 am

Preventing the Progression From Casual to Casualty: An Update on Interventions for Substance Use Disorders

— Hara E. Oyedeji, PMHNP-BC, MS, MSed and Andrew J. Cutler, MD

10:05 am – 10:20 am

Networking Break

10:20 am – 11:15 am

Psyched About Psychedelics? Concerns and Controversies in Using Psychedelics to Treat Mental Health Conditions

— Roger S. McIntyre, MD, FRCPC and Andrew J. Cutler, MD

11:15 am – 12:00 pm

What Matters Most: Focusing on Symptoms and Side Effects That Most Impact the Individual Patient

— Jade Wu, PhD, DBSM, Desiree M. Matthews, MSN, PMHNP-BC, Hara E. Oyedeji, PMHNP-BC, MS, MSed and Rajnish Mago, MD

12:00 pm – 12:05 pm

Closing Remarks & Next Steps

12:10 pm – 1:10 pm

Lunch Industry Session†: Learn More About This Long-Acting Injectable Option for Schizophrenia Treatment in Adults

Sponsored by Alkermes

— Gregory W. Mattingly, MD

— Level 5, Salons G-L

*The agenda is subject to change.

†The content of all industry–sponsored non–CME/CE events (industry session, disease state sessions, and poster sessions) and the views expressed therein are those of the presenting entity and not of NEI. Non–CME/CE events are not part of the scientific program and do not provide CME/CE credit. By attending (or opening) a non–CME/CE event, the attendee opts in to receive follow–up information from the commercial sponsor. Meals for in-person attendees are provided by NEI.